Soluble tumor necrosis factor receptors are present in human vitreous and shed by retinal pigment epithelial cells

Experimental Eye Research

Volumn 63, Issue 3, 1996, Pages 311-317

  Sippy, Brian D ^a   Hofman, Florence M ^a   Wright, Albion D ^a   He, Shikun ^a   Ryan, Stephen J ^a,b   Hinton, David R ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b DOHENY EYE INSTITUTE   (United States)

Author keywords

PKC; protein kinase; RPE; soluble cytokine receptor; TNF binding protein

Indexed keywords

CALPHOSTIN C; PHORBOL 13 ACETATE 12 MYRISTATE; TUMOR NECROSIS FACTOR RECEPTOR;

AGED; ARTICLE; CELL CULTURE; CONTROLLED STUDY; FETUS; HUMAN; HUMAN CELL; PIGMENT EPITHELIUM; PRIORITY JOURNAL; VITREOUS BODY;

EID: 0030249045     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1006/exer.1996.0120     Document Type: Article

References (42)

1. Aderka, D., Engelmann, H., Hornik, V., Skornick, Y., Levo, Y., Wallach, D. and Kushtai, G. (1991). Increased serum levels of soluble receptors for tumor necrosis factor in cancer patients. Cancer Res. 51, 5602-7.
2. Aderka, D., Engelmann, H., Maor, Y., Brakebusch, C. and Wallach, D. (1992). Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J. Exp. Med. 175, 323-9.
3. Aggarwal, B. B. and Eessalu, T. E. (1987). Effect of phorbol esters on down-regulation and redistribution of cell surface receptors for tumor necrosis factor-alpha. J. Biol. Chem. 262, 16450-5.
4. Aguayo, J., Glaser, B., Mildvan, A., Cheng, H. M., Gonzalez, R. G. and Brady, T. (1985). Study of vitreous liquefaction by NMR spectroscopy and imaging. Invest. Ophthalmol. Vis. Sci. 26, 692-7.
5. Bradley, J. R., Thiru, S. and Pober, J. S. (1995). Disparate localization of 55-kd and 75-kd tumor necrosis factor receptors in human endothelial cells. Am. J. Pathol. 146, 27-32.
6. Dembic, Z., Loetscher, H., Gubler, U., Pan, Y. C. E., Lahm, H. W., Gentz, R., Brockhaus, M. and Lesslauer, W. (1990). Two human TNF receptors have similar extracellular, but distinct intracellular, domain sequences. Cytokine 2, 231-7.
7. Engelmann, H., Holtmann, H., Brakebusch, C., Avni, Y. S., Sarov, I., Nophar, Y., Hadas, E., Leitner, O. and Wallach, D. (1990). Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNF-like activity. J. Biol. Chem. 265, 14497-504.
8. Franks, W. A., Limb, G. A., Stanford, M. R., Ogilvie, J. A., Wolstencroft, R. A., Chignell, A. H., Dumonde, D. C. (1992). Cytokines in human intraocular inflammation. Curr. Eye Res. 11(Suppl.), 187-91.
9. Gabrielian, K., Osusky, R., Sippy, B. D., Ryan, S. J. and Hinton, D. R. (1994). Effect of TGF-beta on interferon-gamma-induced HLA-DR expression in human retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 35, 4253-9.
10. Girardin, E., Roux-Lombard, P., Grau, G. E., Suter, P., Gallati, H. and Dayer, J. M. (1992). Imbalance between tumour necrosis factor-alpha and soluble TNF receptor concentrations in severe meningococcaemia. Immunology 76, 20-3.
11. Godfried, M. H., van der Poll, T., Jansen, J., Rominjin, J. A., Schattenkerk, J. K. M. E., Endert, E., van Deventer, S. J. H. and Sauerwein, H. P. (1993). Soluble receptors for tumour necrosis factor: a putative marker of disease progression in HIV infection. AIDS 7, 33-6.
12. Grosen, E. A., Granger, G. A., Gatanaga, M., Ininns, E. K., Hwang, C., DiSaia, P., Berman, M., Manetta, A., Emma, D. and Gatanaga, T. (1993). Measurement of the soluble membrane receptors for tumor necrosis factor and lymphotoxin in the sera of patients with gynecologic malignancy. Gynecol. Oncol. 50, 68-77.
13. Gruss, H. J., Dolken, G., Brach, M. A., Mertelsmann, R., and Herrmann, F. (1993). The significance of serum levels of soluble 60 kDa receptors for tumor necrosis factor in patients with Hodgkin's disease. Leukemia 7, 1339-43.
14. Higuchi, M. and Aggarwal, B. B. (1993). Okadaic acid induces down-modulation and shedding of tumor necrosis factor receptors. J. Biol. Chem. 266, 5624-31.
15. Hofman, F. M. and Hinton, D. R. (1992). Tumor necrosis factor-alpha in the retina in acquired immune deficiency syndrome. Invest. Ophthalmol. Vis. Sci. 33, 1829-35.
16. Hohmann, H. P., Brockhaus, M., Baeuerle, P. A., Remy, R., Kolbeck, R. and van Loon, A. P. G. M. (1990). Expression of the types A and B tumor necrosis factor (TNF) receptors is independently regulated, and both receptors mediate activation of the transcription factor NF-kB. J. Biol. Chem. 265, 22409-17.
17. Hunt, R. C. and Davis, A. A. (1990). Altered expression of keratin and vimentin in human retinal pigment epithelial cells in vivo and in vitro. J. Cell. Physiol. 145, 187-99.
18. Johnson, S. E. and Baglioni, C. (1988). Tumor necrosis factor receptors and cytocidal activity are down-regulated by activators of protein kinase C. J. Biol. Chem. 263, 5686-92.
19. Kauffman, D. J., van Meurs, J. C., Mertens, D. A., Peperkamp, E., Master, C. and Gerritsen, M. E. (1994). Cytokines in vitreous humor: interleukin-6 is elevated in proliferative vitreoretinopathy. Invest. Ophthalmol. Vis. Sci. 35, 900-6.
20. Leeuwenberg, J. F. M., Jeunhomme, T. M. A. A. and Buurman, W. A. (1994). Slow release of soluble TNF receptors by monocytes in vitro. J. Immunol. 152, 4036-43.
21. Liabakk, N. B., Sundan, A., Lien, E., Laegreid, A., Bombara, M. P., Ranges, G. and Espevik, T. (1993). The release of soluble p55 TNF receptor from U937 cells studied by a new p55 immunoassay. J. Immunol. Methods 163, 145-54.
22. Limb, G. A., Little, B. C., Meager, A., Ogilvie, J. A., Wolstencroft, R. A., Franks, W. A., Chignell, A. H., Dumonde, D. C. (1991). Cytokines in proliferative vitreoretinopathy. Eye. 5, 686-93.
23. Loetscher, H. (1992). Purification and structural properties of two distinct TNF receptors on human cells. Immunol. Ser. 56, 161-87.
24. Loetscher, H., Pan, Y. C. E., Lahm, H. W., Gentz, R., Brockhaus, M., Tabuchi, H. and Lessaluer, W. (1990). Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor. Cell 61, 351-9.
25. Mohler, K. M., Torrance, D. S., Smith, C. A., Goodwin, R. G., Stremler, K. E., Fung, V. P., Madani, H. and Widmer, M. B. (1993). Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J. Immunol. 151, 1548-61.
26. Noelle, B., Halene, M., Zavazava, N., Westphal, E., Duncker, G. and Mueller-Ruchholtz, W. (1991). Postmortem serological and biochemical HLA typing with cultivated retinal pigment epithelial cells. Fortschritte Ophthalmol. 88, 629-32.
27. Nophar, Y., Kemper, O., Brakebusch, C., Engelmann, H., Zwang, R., Aderka, D., Holtmann, H. and Wallach, D. (1990). Soluble forms of tumor necrosis factor receptors (TNF-Rs). the cDNA for the type I TNF-R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptor. EMBO J. 9, 3269-78.
28. Olsson, I., Lantz, M., Nilsson, E., Peetre, C., Thysell, H. and Grubb, A. (1989). Isolation and characterization of a tumor necrosis factor binding protein from urine. Eur. J. Haematol. 42, 270-5.
29. Palexas, G. N., Sussman, G. and Welsh N. H. (1992). Ocular and systemic determination of IL-1beta and tumor necrosis factor in a patient with ocular inflammation. Scand. J. Immunol. 36(Suppl.), 173-5.
30. Porteu, F. and Nathan, C. (1990). Shedding of tumor necrosis factor receptors by activated human neutrophils. J. Exp. Med. 172, 599-607.
31. Schall, T. J., Lewis, M., Koller, K. J., Lee, A., Rice, G. C., Wong, G. H. W., Gatanaga, T., Granger, G. A., Lentz, R., Raab, H., Kohr, W.J. and Goeddel, D. V. (1990). Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell 61, 361.
32. Scheurich, P., Kobrich, G. and Pfizenmaier, K. (1989). Antagonistic control of tumor necrosis factor receptors by protein kinases A and C. J. Exp. Med. 170, 947-58.
33. Seckinger, P., Isaaz, S. and Dayer, J. M. (1989). Purification and biologic characterization of a specific tumor necrosis factor inhibitor. J. Biol. Chem. 264, 11966-73.
34. Sippy, B. D., Hofman, F. M., He, S., Osusky, R., Sheu, S. J., Walker, S. M., Ryan, S.J. and Hinton, D. R. (1995a). SV40-immortalized and primary cultured human retinal pigment epithelial cells share similar patterns of cytokine-receptor expression and cytokine responsiveness. Curr. Eye Res. 14, 495-503.
35. Sippy, B.D., Hofman, P.M., Wright, A.D., Wang, J. L., Gopalakrishna, R., Gundimeda, U., He, S., Ryan, S. J. and Hinton, D. R. (1996). Induction of intercellular adhesion molecule-1 by tumor necrosis factor-α through the 55-kDa receptor is dependent on protein kinase C in human retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 37, 597-606.
36. Smith, C. A., Farrah, T. and Goodwin, R. G. (1994). The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 76, 959-62.
37. Spranger, J., Meyer-Schwickerath, R., Klein, M., Schatz, H. and Pfeiffer, A. (1995). TNF-alpha level in the vitreous body. Increase in neovascular eye diseases and proliferative diabetic retinopathy. Medizinische Klinik. 90, 134-7.
38. Streilein, J. W., Wilbanks, G. A. and Cousins, S. W. (1992). Immunoregulatory mechanisms of the eye. J. Neuroimmunol. 39, 185-200.
39. Tartaglia, L. A. and Goeddel, D. V. (1992). Two TNF receptors. Immunol. Today 13, 151-3.
40. Unglaub, R., Maxeiner, B., Thoma, B., Pfizenmaier, K. and Scheurich, P. (1987). Downregulation of tumor necrosis factor (TNF) sensitivity via modulation of TNF binding capacity by protein kinase C activators. J. Exp. Med. 166, 1788-97.
41. Villard, J., Roux-Lombard, P., Hugli, A. and Dayer, J. M. (1993). Could natural inhibitors of tumor necrosis factor-alpha modify the clinical course of fulminant meningococcemia? 21, 1396-1400.
42. Zhang, L., Higuchi, M., Totpal, K., Chaturvedi, M. M. and Aggarwal, B. B. (1994). Staurosporine induces the cell surface expression of both forms of human necrosis factor receptors on myeloid and epithelial cells and modulates ligand-induced cellular response. J. Biol. Chem. 269, 10270-9.